Recherche
Enseignement
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Institute for Medical Virology
Jovan Pavlovic has not added Biography.
If you are Jovan Pavlovic and would like to personalize this page please email our Author Liaison for assistance.
Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice.
Experimental dermatology Jun, 2002 | Pubmed ID: 12102662
Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice.
Journal of virology Sep, 2002 | Pubmed ID: 12163608
IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency.
Experimental dermatology Jun, 2004 | Pubmed ID: 15186325
Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
Journal of molecular medicine (Berlin, Germany) Oct, 2004 | Pubmed ID: 15241501
Transfection of a mouse dendritic cell line by plasmid DNA-loaded PLGA microparticles in vitro.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V Nov, 2004 | Pubmed ID: 15451523
Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy.
Human gene therapy Jan, 2005 | Pubmed ID: 15703487
Effect of ex vivo gene transfer with an adenoviral vector on human eye bank corneas.
Ophthalmic research Mar-Apr, 2005 | Pubmed ID: 15746561
Analysis of antitumor activity elicited by vaccination with combinations of interleukin-12 DNA with gp100 DNA or the chemokine CCL21 in vivo.
Human gene therapy Aug, 2006 | Pubmed ID: 16942445
Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model.
Experimental dermatology Nov, 2006 | Pubmed ID: 17002683
Attenuated measles virus as a vaccine vector.
Vaccine Apr, 2007 | Pubmed ID: 17303293
Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens.
The Journal of general virology May, 2007 | Pubmed ID: 17412966
Virulence of a mouse-adapted Semliki Forest virus strain is associated with reduced susceptibility to interferon.
The Journal of general virology Jul, 2007 | Pubmed ID: 17554028
RIP2 mediates LPS-induced p38 and IkappaBalpha signaling including IL-12 p40 expression in human monocyte-derived dendritic cells.
European journal of immunology Aug, 2007 | Pubmed ID: 17578844
Role of AF6 protein in cell-to-cell spread of Herpes simplex virus 1.
FEBS letters Nov, 2007 | Pubmed ID: 17967423
Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides.
Archives of virology , 2009 | Pubmed ID: 19034603
The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection.
Journal of virology Sep, 2011 | Pubmed ID: 21680511
Interferon-induced antiviral protein MxA interacts with the cellular RNA helicases UAP56 and URH49.
The Journal of biological chemistry Oct, 2011 | Pubmed ID: 21859714
Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells.
Retrovirology Mar, 2012 | Pubmed ID: 22458358
Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus.
The Journal of biological chemistry Dec, 2015 | Pubmed ID: 26507657
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.
Retrovirology Sep, 2016 | Pubmed ID: 27595568
University of Zurich
Patricia E. Nigg1,2,
Jovan Pavlovic1
1Institute for Medical Virology, University of Zurich,
2, Friedrich Miescher Institute for Biomedical Research
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.